These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3445022

  • 1. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
    Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyana M, Tateno S.
    Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
    [No Abstract] [Full Text] [Related]

  • 2. Natural history of IgA nephropathy in Japan.
    Tojo S, Hatano M, Honda N, Miyahara T, Sugino N, Narita M, Sakai H.
    Semin Nephrol; 1987 Dec; 7(4):386-8. PubMed ID: 3445023
    [No Abstract] [Full Text] [Related]

  • 3. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
    Suzuki T, Yamamoto T, Ohura M, Fujigaki Y, Yonemura K, Kimura M, Hishida A.
    Clin Exp Nephrol; 2004 Sep; 8(3):243-9. PubMed ID: 15480902
    [Abstract] [Full Text] [Related]

  • 4. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN, Lai FM, Ho CP, Chan KW.
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [Abstract] [Full Text] [Related]

  • 5. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
    Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S.
    Nephron; 1996 Oct; 72(2):237-42. PubMed ID: 8684533
    [Abstract] [Full Text] [Related]

  • 6. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y, Fujii K, Hiki Y, Tateno S.
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [Abstract] [Full Text] [Related]

  • 7. [IgA nephropathy].
    Alamartine E.
    Rev Prat; 2003 Nov 30; 53(18):2023-6. PubMed ID: 15008216
    [Abstract] [Full Text] [Related]

  • 8. [IgA nephropathy (immunoglobulin A nephropathy, M.Berger). Main symptoms: (painless) macrohematuria or microhematuria].
    Kolyvanos Naumann U, Käser L, Vetter W.
    Praxis (Bern 1994); 2004 Oct 27; 93(44):1809-13; quiz 1814. PubMed ID: 15559904
    [No Abstract] [Full Text] [Related]

  • 9. [Early treatment of IgA nephritis is indicated by prognostic factors].
    Barth C.
    Dtsch Med Wochenschr; 2000 Aug 25; 125(34-35):1009. PubMed ID: 11004913
    [No Abstract] [Full Text] [Related]

  • 10. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T, Lepenies J, Nightingale P, Howie AJ, Adu D, Harper L.
    Nephron Clin Pract; 2009 Aug 25; 112(1):c16-24. PubMed ID: 19342865
    [Abstract] [Full Text] [Related]

  • 11. [A clinico-pathological study on a long-term outcome of IgA nephropathy].
    Oohashi T.
    Igaku Kenkyu; 1988 Dec 25; 58(6):396-410. PubMed ID: 3252679
    [No Abstract] [Full Text] [Related]

  • 12. [Study on a predictive marker for evaluating the effectiveness of steroid therapy in IgA nephropathy-significance of extracapillary changes].
    Yamamoto S, Iesato K, Yoshida H, Hori J, Hasegawa R, Ohta Y, Akikusa B, Kondo Y.
    Nihon Jinzo Gakkai Shi; 1996 Feb 25; 38(2):74-83. PubMed ID: 8717309
    [Abstract] [Full Text] [Related]

  • 13. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep 25; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 14. Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
    Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S.
    Nephron; 1989 Sep 25; 53(3):250-6. PubMed ID: 2797345
    [Abstract] [Full Text] [Related]

  • 15. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep 25; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 16. [First case of primary IgA glomerulonephritis (Berger's disease) in Senegal].
    Diouf B, Diao M, Niang A, Ka EF, Moreira Diop T.
    Dakar Med; 1999 Sep 25; 44(1):140-2. PubMed ID: 10798006
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan 25; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 18. Prognostic indicators and treatment of childhood IgA nephropathy.
    Hogg RJ.
    Contrib Nephrol; 1995 Jan 25; 111():194-9; discussion 199-200. PubMed ID: 7758342
    [No Abstract] [Full Text] [Related]

  • 19. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 25; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 20. Effect of corticosteroids on renal function in progressive IgA nephropathy--long-term follow-up study.
    Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyama M, Tateno S.
    Nihon Jinzo Gakkai Shi; 1988 Sep 25; 30(9):1135-42. PubMed ID: 3216556
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.